Signorovitch J - Search Results

1

Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial.

Reich K, Signorovitch J, Ramakrishnan K, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani PM. Reich K, et al. Among authors: signorovitch j. J Am Acad Dermatol. 2010 Dec;63(6):1011-8. doi: 10.1016/j.jaad.2009.12.029. Epub 2010 Oct 8. J Am Acad Dermatol. 2010. PMID: 20933301

2

Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials.

Gordon KB, Betts KA, Sundaram M, Signorovitch JE, Li J, Xie M, Wu EQ, Okun MM. Gordon KB, et al. Among authors: signorovitch je. J Am Acad Dermatol. 2017 Dec;77(6):1030-1037. doi: 10.1016/j.jaad.2017.08.017. Epub 2017 Oct 6. J Am Acad Dermatol. 2017. PMID: 28993007 Clinical Trial.

3

Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.

Mease PJ, Signorovitch J, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani PM. Mease PJ, et al. Among authors: signorovitch j. Dermatology. 2010;220(1):1-7. doi: 10.1159/000260371. Epub 2009 Nov 19. Dermatology. 2010. PMID: 19940437 Free article.

4

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.

Menter A, Augustin M, Signorovitch J, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani P. Menter A, et al. Among authors: signorovitch j. J Am Acad Dermatol. 2010 May;62(5):812-8. doi: 10.1016/j.jaad.2009.07.022. Epub 2010 Mar 9. J Am Acad Dermatol. 2010. PMID: 20219265 Clinical Trial.

5

The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.

Kimball AB, Yu AP, Signorovitch J, Xie J, Tsaneva M, Gupta SR, Bao Y, Mulani PM. Kimball AB, et al. Among authors: signorovitch j. J Am Acad Dermatol. 2012 Feb;66(2):e67-76. doi: 10.1016/j.jaad.2010.10.020. Epub 2011 May 25. J Am Acad Dermatol. 2012. PMID: 21616560 Clinical Trial.

6

Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response.

Signorovitch JE, Betts KA, Yan YS, LeReun C, Sundaram M, Wu EQ, Mulani P. Signorovitch JE, et al. Br J Dermatol. 2015 Feb;172(2):504-12. doi: 10.1111/bjd.13437. Epub 2015 Jan 21. Br J Dermatol. 2015. PMID: 25288183 Review.

7

Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study.

Papp KA, Sundaram M, Bao Y, Williams DA, Gu Y, Signorovitch JE, Wang Y, Valdes JM, Mulani PM. Papp KA, et al. Among authors: signorovitch je. J Eur Acad Dermatol Venereol. 2014 Jun;28(6):790-8. doi: 10.1111/jdv.12177. Epub 2013 May 17. J Eur Acad Dermatol Venereol. 2014. PMID: 23679896 Clinical Trial.

8

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.

Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM. Signorovitch JE, et al. Pharmacoeconomics. 2010;28(10):935-45. doi: 10.2165/11538370-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831302

9

Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.

Papp KA, Signorovitch J, Ramakrishnan K, Yu AP, Gupta SR, Bao Y, Mulani PM. Papp KA, et al. Among authors: signorovitch j. Clin Drug Investig. 2011;31(1):51-60. doi: 10.2165/11539360-000000000-00000. Clin Drug Investig. 2011. PMID: 20932070

10

Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis.

Armstrong AW, Betts KA, Signorovitch JE, Sundaram M, Li J, Ganguli AX, Wu EQ. Armstrong AW, et al. Among authors: signorovitch je. Curr Med Res Opin. 2018 Jul;34(7):1325-1333. doi: 10.1080/03007995.2018.1457516. Epub 2018 Apr 23. Curr Med Res Opin. 2018. PMID: 29619856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters